INTRODUCTION: This study was conducted to prospectively evaluate the diagnostic value of detailed neurological evaluation, transcranial Doppler sonography (TCD) and Perfusion-CT (PCT) to predict delayed vasospasm (DV) and delayed cerebral infarction (DCI) within the following 3 days in patients with aneurysmal subarachnoid hemorrhage (SAH). METHODS: A total of 61 patients with aneurysmal SAH were included in the study. All patients were amenable for neurological evaluation throughout the critical phase to develop secondary ischemia after SAH. The neurological status was assessed three times a day according to a detailed examination protocol. Mean flow velocities (MFV) in intracranial vessel trunks were measured daily by TCD. Native CT and PCT were routinely acquired at 3-day intervals and, in addition, whenever it was thought to be of diagnostic relevance. The predictive values of abnormal PCT and accelerations in TCD (MFV > 140 cm/s) to detect angiographic DV and DCI within the following 2 days were calculated and compared to the predictive value of delayed ischemic neurological deficits (DIND). RESULTS: The accuracy of TCD and PCT to predict DV or DCI was 0.65 and 0.63, respectively. In comparison, DIND predicted DV or DCI with an accuracy of 0.96. Pathological PCT findings had a higher sensitivity (0.93) and negative predictive value (0.98) than TCD (0.81 and 0.96). CONCLUSION: Neurological assessment at close intervals is the most accurate parameter to detect DV and DCI in the following 3 days. However, DIND may not be reversible. The routine acquisition of PCT in addition to daily TCD examinations seems reasonable, particularly in patients who are not amenable to a detailed neurological examination since it has a higher sensitivity and negative predictive value than TCD and leaves a lower number of undetected cases of vasospasm and infarction.
INTRODUCTION: This study was conducted to prospectively evaluate the diagnostic value of detailed neurological evaluation, transcranial Doppler sonography (TCD) and Perfusion-CT (PCT) to predict delayed vasospasm (DV) and delayed cerebral infarction (DCI) within the following 3 days in patients with aneurysmal subarachnoid hemorrhage (SAH). METHODS: A total of 61 patients with aneurysmalSAH were included in the study. All patients were amenable for neurological evaluation throughout the critical phase to develop secondary ischemia after SAH. The neurological status was assessed three times a day according to a detailed examination protocol. Mean flow velocities (MFV) in intracranial vessel trunks were measured daily by TCD. Native CT and PCT were routinely acquired at 3-day intervals and, in addition, whenever it was thought to be of diagnostic relevance. The predictive values of abnormal PCT and accelerations in TCD (MFV > 140 cm/s) to detect angiographic DV and DCI within the following 2 days were calculated and compared to the predictive value of delayed ischemic neurological deficits (DIND). RESULTS: The accuracy of TCD and PCT to predict DV or DCI was 0.65 and 0.63, respectively. In comparison, DIND predicted DV or DCI with an accuracy of 0.96. Pathological PCT findings had a higher sensitivity (0.93) and negative predictive value (0.98) than TCD (0.81 and 0.96). CONCLUSION: Neurological assessment at close intervals is the most accurate parameter to detect DV and DCI in the following 3 days. However, DIND may not be reversible. The routine acquisition of PCT in addition to daily TCD examinations seems reasonable, particularly in patients who are not amenable to a detailed neurological examination since it has a higher sensitivity and negative predictive value than TCD and leaves a lower number of undetected cases of vasospasm and infarction.
Authors: Jens P Dreier; Johannes Woitzik; Martin Fabricius; Robin Bhatia; Sebastian Major; Chistoph Drenckhahn; Thomas-Nicolas Lehmann; Asita Sarrafzadeh; Lisette Willumsen; Jed A Hartings; Oliver W Sakowitz; Jörg H Seemann; Anja Thieme; Martin Lauritzen; Anthony J Strong Journal: Brain Date: 2006-10-25 Impact factor: 13.501
Authors: Walter M van den Bergh; A Algra; F van Kooten; C M F Dirven; J van Gijn; M Vermeulen; G J E Rinkel Journal: Stroke Date: 2005-03-24 Impact factor: 7.914
Authors: Thomas Westermaier; Christian Stetter; Giles H Vince; Mirko Pham; Jose Perez Tejon; Jörg Eriskat; Ekkehard Kunze; Cordula Matthies; Ralf-Ingo Ernestus; Laszlo Solymosi; Klaus Roosen Journal: Crit Care Med Date: 2010-05 Impact factor: 7.598
Authors: Bert Bosche; Rudolf Graf; Ralf-Ingo Ernestus; Christian Dohmen; Thomas Reithmeier; Gerrit Brinker; Anthony J Strong; Jens P Dreier; Johannes Woitzik Journal: Ann Neurol Date: 2010-05 Impact factor: 10.422
Authors: Anne-Katrin Hickmann; Sönke Langner; Michael Kirsch; Jörg Baldauf; Cornelia Müller; Alexander Khaw; Henry W S Schroeder Journal: Neurosurg Rev Date: 2012-10-27 Impact factor: 3.042
Authors: M Pham; A Johnson; A J Bartsch; C Lindner; W Müllges; K Roosen; L Solymosi; M Bendszus Journal: Neurology Date: 2007-08-21 Impact factor: 9.910
Authors: Rickard L Sjöberg; Tommy Bergenheim; Lina Mörén; Henrik Antti; Cecilia Lindgren; Silvana Naredi; Peter Lindvall Journal: Neurocrit Care Date: 2015-10 Impact factor: 3.210
Authors: Sahar F Zafar; M Brandon Westover; Nicolas Gaspard; Emily J Gilmore; Brandon P Foreman; Kathryn L OʼConnor; Eric S Rosenthal Journal: J Clin Neurophysiol Date: 2016-06 Impact factor: 2.177
Authors: Daniel Appel; Miriam Seeberger; Edzard Schwedhelm; Patrick Czorlich; Alwin E Goetz; Rainer H Böger; Juliane Hannemann Journal: Neurocrit Care Date: 2018-08 Impact factor: 3.210
Authors: Azade Tabaie; Shamim Nemati; Jason W Allen; Charlotte Chung; Flavia Queiroga; Won-Jun Kuk; Adam B Prater Journal: AMIA Annu Symp Proc Date: 2020-03-04
Authors: Thomas Westermaier; Christian Stetter; Ekkehard Kunze; Nadine Willner; Judith Holzmeier; Judith Weiland; Stefan Koehler; Christopher Lotz; Christian Kilgenstein; Ralf-Ingo Ernestus; Norbert Roewer; Ralf Michael Muellenbach Journal: Neurocrit Care Date: 2016-10 Impact factor: 3.210